Ting Feng
Direktor/Vorstandsmitglied bei Beijing Jiakesi New Drug Development Co. Ltd.
Profil
Ting Feng, Ph.D., is a Vice President with Lilly Asia Ventures (LAV).
Prior to joining LAV, Ting was a Senior Investment Manager at SAIF Partners, focusing on healthcare investment in China.
Prior to SAIF, Ting worked as a Senior Consultant at IMS Consulting Group and postdoctoral fellow at Harvard Medical School.
Ting holds a Ph.D.
in Immunology from University of Alabama at Birmingham and B.S.
in Biotechnology from Wuhan University.
Aktive Positionen von Ting Feng
| Unternehmen | Position | Beginn |
|---|---|---|
Beijing Jiakesi New Drug Development Co. Ltd.
 Beijing Jiakesi New Drug Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Jiakesi New Drug Development Co. Ltd. develops and sells drugs. The company was founded by Yinxiang Wang on July 17, 2015 and is headquartered in Beijing, China. | Direktor/Vorstandsmitglied | 01.02.2020 |
| Jacobio Hk Pharmaceuticals Co. Ltd. | Direktor/Vorstandsmitglied | 01.02.2020 |
| Lav Advanced Management Shanghai Co. Ltd. | Corporate Officer/Principal | 01.12.2018 |
Synnovation Therapeutics, Inc.
 Synnovation Therapeutics, Inc. BiotechnologyHealth Technology Synnovation Therapeutics, Inc. develops novel small molecule targeted therapies for cancer patients. The company is located in the US. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Ting Feng
| Unternehmen | Position | Ende |
|---|---|---|
| JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Direktor/Vorstandsmitglied | 22.03.2022 |
LAV Management Co., Ltd.
 LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Private Equity Investor | 01.01.2022 |
SAIF Partners Ltd. (China)
 SAIF Partners Ltd. (China) Investment ManagersFinance SAIF Partners China is the China-based private equity subsidiary of SAIF Partners Hong Kong, a leading private equity firm that provides growth capital to companies in Asia. Founded in 2001, SAIF Partners China has offices in Beijing, Shanghai and Tianjin. In addition to the Chinese offices, SAIF Partners has their headquarters in Hong Kong, with dedicated local offices in India (Hyderabad, New Delhi), and South Korea (Seoul). | Chief Investment Officer | 01.11.2018 |
Ausbildung von Ting Feng
| Wuhan University | Undergraduate Degree |
| The University of Alabama at Birmingham | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Beijing Jiakesi New Drug Development Co. Ltd.
Beijing Jiakesi New Drug Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Jiakesi New Drug Development Co. Ltd. develops and sells drugs. The company was founded by Yinxiang Wang on July 17, 2015 and is headquartered in Beijing, China. | Health Technology |
| Jacobio Hk Pharmaceuticals Co. Ltd. | |
SAIF Partners Ltd. (China)
SAIF Partners Ltd. (China) Investment ManagersFinance SAIF Partners China is the China-based private equity subsidiary of SAIF Partners Hong Kong, a leading private equity firm that provides growth capital to companies in Asia. Founded in 2001, SAIF Partners China has offices in Beijing, Shanghai and Tianjin. In addition to the Chinese offices, SAIF Partners has their headquarters in Hong Kong, with dedicated local offices in India (Hyderabad, New Delhi), and South Korea (Seoul). | Finance |
| Lav Advanced Management Shanghai Co. Ltd. | |
Synnovation Therapeutics, Inc.
Synnovation Therapeutics, Inc. BiotechnologyHealth Technology Synnovation Therapeutics, Inc. develops novel small molecule targeted therapies for cancer patients. The company is located in the US. | Health Technology |
LAV Management Co., Ltd.
LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Finance |
